-
Je něco špatně v tomto záznamu ?
Effect of erythropoietin on hepcidin expression in hemojuvelin-mutant mice
J. Krijt, A. Jonásová, R. Neuwirtová, E. Necas,
Jazyk angličtina Země Spojené státy americké
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- down regulace účinky léků MeSH
- erythropoetin farmakologie MeSH
- erytropoéza účinky léků genetika MeSH
- genetická transkripce účinky léků MeSH
- játra účinky léků metabolismus MeSH
- kationické antimikrobiální peptidy biosyntéza genetika MeSH
- kostní morfogenetický protein 6 biosyntéza genetika MeSH
- membránové proteiny nedostatek genetika fyziologie MeSH
- messenger RNA biosyntéza MeSH
- myši inbrední C57BL MeSH
- myši knockoutované MeSH
- myši MeSH
- polysacharidy farmakologie toxicita MeSH
- přetížení železem chemicky indukované metabolismus MeSH
- regulace genové exprese účinky léků MeSH
- rekombinantní proteiny MeSH
- železité sloučeniny farmakologie toxicita MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- myši MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Transcription of the hepcidin (Hamp) gene is controlled by iron stores and the rate of erythropoiesis. Functional hierarchy between these two stimuli has not yet been completely established. It is also not known whether the erythropoiesis-related downregulation of Hamp expression utilises the bone morphogenetic protein/hemojuvelin (Bmp/Hjv) pathway. Hemojuvelin-mutant (Hjv-/-) mice treated with erythropoietin (EPO) at 50IU/mouse/day for three days displayed marked decrease in Hamp mRNA, demonstrating that hemojuvelin is not an indispensable component in EPO-induced Hamp gene downregulation. Irradiation of Hjv-/- mice prevented the EPO-induced decrease of Hamp mRNA, highlighting the role of erythropoiesis in Hamp gene regulation by EPO. After a single injection of EPO, Hamp mRNA levels were not significantly changed at 6h, but decreased at 10 and 24h. Chronic bleeding decreased hepatic Bmp6 mRNA levels; however, repeated EPO treatment did not change Bmp6 mRNA, suggesting that the erythropoietic regulator(s) act independently of the Bmp/Hjv pathway. Pretreatment of C57BL/6 mice with iron (5mg/mouse) almost completely inhibited the EPO-induced decrease of Hamp mRNA. This result suggests that administration of EPO to patients with transfusional iron overload is probably not associated with the risk of additional absorption of substantial amounts of iron from the diet.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12025883
- 003
- CZ-PrNML
- 005
- 20121206121059.0
- 007
- ta
- 008
- 120817e20100312xxu f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.bcmd.2010.02.012 $2 doi
- 035 __
- $a (PubMed)20219396
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Krijt, Jan $u Institute of Pathophysiology and Center of Experimental Haematology, Charles University in Prague, First Faculty of Medicine, Prague 2, Czech Republic. JKRI@LF1.CUNI.CZ <JKRI@LF1.CUNI.CZ>
- 245 10
- $a Effect of erythropoietin on hepcidin expression in hemojuvelin-mutant mice / $c J. Krijt, A. Jonásová, R. Neuwirtová, E. Necas,
- 520 9_
- $a Transcription of the hepcidin (Hamp) gene is controlled by iron stores and the rate of erythropoiesis. Functional hierarchy between these two stimuli has not yet been completely established. It is also not known whether the erythropoiesis-related downregulation of Hamp expression utilises the bone morphogenetic protein/hemojuvelin (Bmp/Hjv) pathway. Hemojuvelin-mutant (Hjv-/-) mice treated with erythropoietin (EPO) at 50IU/mouse/day for three days displayed marked decrease in Hamp mRNA, demonstrating that hemojuvelin is not an indispensable component in EPO-induced Hamp gene downregulation. Irradiation of Hjv-/- mice prevented the EPO-induced decrease of Hamp mRNA, highlighting the role of erythropoiesis in Hamp gene regulation by EPO. After a single injection of EPO, Hamp mRNA levels were not significantly changed at 6h, but decreased at 10 and 24h. Chronic bleeding decreased hepatic Bmp6 mRNA levels; however, repeated EPO treatment did not change Bmp6 mRNA, suggesting that the erythropoietic regulator(s) act independently of the Bmp/Hjv pathway. Pretreatment of C57BL/6 mice with iron (5mg/mouse) almost completely inhibited the EPO-induced decrease of Hamp mRNA. This result suggests that administration of EPO to patients with transfusional iron overload is probably not associated with the risk of additional absorption of substantial amounts of iron from the diet.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kationické antimikrobiální peptidy $x biosyntéza $x genetika $7 D023181
- 650 _2
- $a kostní morfogenetický protein 6 $x biosyntéza $x genetika $7 D055418
- 650 _2
- $a down regulace $x účinky léků $7 D015536
- 650 _2
- $a erytropoéza $x účinky léků $x genetika $7 D004920
- 650 _2
- $a erythropoetin $x farmakologie $7 D004921
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a železité sloučeniny $x farmakologie $x toxicita $7 D005290
- 650 _2
- $a regulace genové exprese $x účinky léků $7 D005786
- 650 _2
- $a přetížení železem $x chemicky indukované $x metabolismus $7 D019190
- 650 _2
- $a játra $x účinky léků $x metabolismus $7 D008099
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a membránové proteiny $x nedostatek $x genetika $x fyziologie $7 D008565
- 650 _2
- $a myši $7 D051379
- 650 _2
- $a myši inbrední C57BL $7 D008810
- 650 _2
- $a myši knockoutované $7 D018345
- 650 _2
- $a polysacharidy $x farmakologie $x toxicita $7 D011134
- 650 _2
- $a messenger RNA $x biosyntéza $7 D012333
- 650 _2
- $a rekombinantní proteiny $7 D011994
- 650 _2
- $a genetická transkripce $x účinky léků $7 D014158
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Jonásová, Anna
- 700 1_
- $a Neuwirtová, Radana
- 700 1_
- $a Necas, Emanuel
- 773 0_
- $w MED00005053 $t Blood cells, molecules & diseases $x 1096-0961 $g Roč. 44, č. 4 (20100312), s. 257-61
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/20219396 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121206121132 $b ABA008
- 999 __
- $a ok $b bmc $g 947925 $s 783229
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2010 $b 44 $c 4 $d 257-61 $e 20100312 $i 1096-0961 $m Blood cells, molecules, & diseases $n Blood Cells Mol Dis $x MED00005053
- LZP __
- $a Pubmed-20120817/10/03